These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6392886)

  • 1. Antifungal drug susceptibility testing. A critical review.
    Stevens DA
    Mycopathologia; 1984 Sep; 87(3):135-40. PubMed ID: 6392886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibility testing.
    Fothergill AW; Rinaldi MG; Sutton DA
    Infect Dis Clin North Am; 2006 Sep; 20(3):699-709. PubMed ID: 16984876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of antifungal susceptibility testing methods.
    Arikan S
    Med Mycol; 2007 Nov; 45(7):569-87. PubMed ID: 17885947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal susceptibility testing: practical aspects and current challenges.
    Rex JH; Pfaller MA; Walsh TJ; Chaturvedi V; Espinel-Ingroff A; Ghannoum MA; Gosey LL; Odds FC; Rinaldi MG; Sheehan DJ; Warnock DW
    Clin Microbiol Rev; 2001 Oct; 14(4):643-58, table of contents. PubMed ID: 11585779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
    Lass-Flörl C; Perkhofer S; Mayr A
    Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of antifungal susceptibility testing.
    Galgiani JN; Rinaldi MG; Polak AM; Pfaller MA
    J Med Vet Mycol; 1992; 30 Suppl 1():213-24. PubMed ID: 1474447
    [No Abstract]   [Full Text] [Related]  

  • 10. Antifungal susceptibility testing: a primer for clinicians.
    Kuper KM; Coyle EA; Wanger A
    Pharmacotherapy; 2012 Dec; 32(12):1112-22. PubMed ID: 23165897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of antifungal susceptibility testing.
    Cormican MG; Pfaller MA
    J Antimicrob Chemother; 1996 Oct; 38(4):561-78. PubMed ID: 8937952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility testing of fungi: current status of the standardization process.
    Galgiani JN
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2517-21. PubMed ID: 8109912
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifungal susceptibility testing: progress and future developments.
    Pfaller MA
    Braz J Infect Dis; 2000 Apr; 4(2):55-60. PubMed ID: 11012296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
    Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
    Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing methods of antifungal agents.
    Ernst EJ
    Methods Mol Med; 2005; 118():3-12. PubMed ID: 15888930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.